Resources Type:
References
DocTalks
Webinars
Resources Type:

Articles you may like

Effects of Vaccination and Monoclonal Antibodies on the Outcome of Covid-19 in Patients with Haematological Malignancies
Hematology, Oncology
Clinical Course of Covid-19 After Kidney Transplantation
Hematology, Oncology
Latest Updates on SARS-CoV-2 Immunity
Hematology, Oncology
An Italian real-world experience on the use of tixagevimab/cilgavimab prophylaxis in lung transplant patients during the omicron wave
Hematology, Oncology
NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOMES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
Hematology, Oncology
EFFECTIVENESS OF COVID-19 VACCINE IN PATIENTS UNDERGOING HEMODIALYSIS
Hematology, Oncology
ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
Anesthesiology, familymedicine, generalpractitioner, Internalmedicine
Clinical Burden of RSV Disease
Hematology, Oncology
Respiratory viral infections in the elderly population: several clinical presentations and outcomes
Hematology, Oncology

An Italian real-world experience on the use of tixagevimab/cilgavimab prophylaxis in lung transplant patients during the omicron wave

Hematology, Oncology

Articles you may like
Effects of Vaccination and Monoclonal Antibodies on the Outcome of Covid-19 in Patients with Haematological Malignancies
Hematology, Oncology
Clinical Course of Covid-19 After Kidney Transplantation
Powered by Merck
Hematology, Oncology
Latest Updates on SARS-CoV-2 Immunity
Hematology, Oncology
An Italian real-world experience on the use of tixagevimab/cilgavimab prophylaxis in lung transplant patients during the omicron wave
Hematology, Oncology
NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOMES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
Powered by Merck
Hematology, Oncology
EFFECTIVENESS OF COVID-19 VACCINE IN PATIENTS UNDERGOING HEMODIALYSIS
Powered by Merck
Hematology, Oncology
ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
Powered by Merck
Anesthesiology, familymedicine, generalpractitioner, Internalmedicine
Clinical Burden of RSV Disease
Hematology, Oncology
Respiratory viral infections in the elderly population: several clinical presentations and outcomes
Hematology, Oncology
Doctalks you may like
Difference Between Vaccine and mAbs
hematology, oncology
Why Use Monoclonical Antibodies to Prevent Infections?
hematology, oncology
Understanding Where Antibodies Come From
hematology, oncology
Navigating Vulnerability : Unveiling COVID-19’s Impact on High Risk
hematology, oncology
Webinars you may like
Difference Between Vaccines and MABs
hematology, oncology
Why Use Monoclonical Antibodies to Prevent Infections?
hematology, oncology
Understanding Where Antibodies Come From
hematology, oncology
Navigating Vulnerability : Unveiling COVID-19’s Impact on High Risk
hematology, oncology
Company
Doctors
Resources
Newsletter

Subscribe to our newsletter to get the latest news and updates

Based on 15,000+ reviews on
4.5/5

© 2023 | docquity.com. All rights reserved

Layanan Pengaduan Konsumen

Docquity Indonesia

WeWork Lim Tower 3, 29A Nguyen Dinh Chieu, Da Kao Ward, District 1, HCMC, Vietnam
For queries: +62 813 1765 2675 (9 AM - 9 PM JKT)

Direktorat Jenderal Perlindungan Konsumen dan Tertib Niaga Kementerian Perdagangan Republik Indonesia

+628531111010

Resources

Company

About Us

A community of experts and leaders in health tech.

Careers

Come work with us.

Cookie Consent

We use cookies to improve your browsing experience on our website. By continuing to use our site, you consent to our use of cookies in accordance with our Privacy Policy. You can learn more about how we use cookies in our Privacy Policy.
Accept & Close